Application of protein language models for antibody developability prediction
Open Access
- 20 March 2026
- journal article
- research article
- Published by Taylor & Francis in mAbs
- Vol. 18 (1) , 2647489
Abstract
1. Monoclonal antibodies (mAbs) have emerged as one of the most successful classes of biotherapeutics, with over 200 FDA-approved antibodies currently in clinical use.1,2 Their high specificity and...Keywords
This publication has 23 references indexed in Scilit:
- Five computational developability guidelines for therapeutic antibody profilingProceedings of the National Academy of Sciences, 2019
- Observed Antibody Space: A Resource for Data Mining Next-Generation Sequencing of Antibody RepertoiresThe Journal of Immunology, 2018
- Clustering huge protein sequence sets in linear timeNature Communications, 2018
- UniProt: the universal protein knowledgebaseNucleic Acids Research, 2018
- Prediction of delayed retention of antibodies in hydrophobic interaction chromatography from sequence using machine learningBioinformatics, 2017
- Biophysical properties of the clinical-stage antibody landscapeProceedings of the National Academy of Sciences, 2017
- Aggregation risk prediction for antibodies and its application to biotherapeutic developmentmAbs, 2015
- Clinical development success rates for investigational drugsNature Biotechnology, 2014
- Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation PropensityJournal of Pharmaceutical Sciences, 2012
- Structure-based engineering of a monoclonal antibody for improved solubilityProtein Engineering, Design and Selection, 2010